HHS has announced that GHK-Cu is expected to return to Category 1, which would restore compounding access for injectable formulations. BPC-157 On 23 July 2026, PCAC voted to recommend adding BPC-157 to the 503A Bulks List, against FDA staff, who had recommended against listing
Additionally, neurological symptoms, such as numbness and tingling in the limbs, can manifest due to B12 deficiency
The 6-8 week treatment duration often extends to 12 weeks for more severe TFCC tears
Any consideration of dose belongs completely within controlled laboratory experiments, institutional review processes, and the oversight of qualified professionals
Shelf life 2436 months when stored correctly in sealed format
Levels over .30 typically cause unconsciousness, and breathing can stop at .45